{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:48:42Z","timestamp":1793148522006,"version":"4.5.0"},"reference-count":25,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Background: Pulmonary hypertension (PH) can lead to cardiac failure, thereby significantly affecting life expectancy and quality of life. Due to inadequate disease surveillance and risk assessment, clinical challenges persist despite advances in diagnosis and treatment. We aimed to review the potential of high-sensitivity cardiac troponin (hs-cTn) as a biomarker for predicting outcomes in PH patients. Methods: A thorough examination of the PubMed and Google Scholar databases was conducted through March 2023. Studies involving adult PH patients and hsTn as a prognostic indicator of outcomes such as mortality, hospitalization, and disease progression were included, after screening their titles and abstracts. Two independent evaluators extracted data, with the quality assessed using the JBI critical appraisal tool. Results: This review uncovered eight studies that examined the prognostic value of hs-cTn in PH patients. Higher hs-cTn levels were associated with increased mortality and hospitalization rates, according to the studies. The severity of PH, cardiac dysfunction, right ventricular function, and systolic dysfunction were associated with hs-cTn. Multiple studies have demonstrated that hsTn has the potential to identify high-risk PH patients who could benefit from targeted therapies and increased clinical monitoring. Conclusions: This review suggests that hsTn may be a biomarker for PH risk stratification and prognosis. Across PH subtypes, elevated hsTn levels predict poor outcomes. However, large-scale prospective studies are needed to confirm hs-cTn\u2019s function in diagnosing pulmonary hypertension and determine its potential value in treatment.<\/jats:p>","DOI":"10.3390\/healthcare12202037","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T12:44:31Z","timestamp":1728909871000},"page":"2037","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["High-Sensitivity Cardiac Troponin [hs-cTn] as a Valuable Biomarker for Pulmonary Hypertension Risk Stratification: A Contemporary Review of the Literature"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8144-9621","authenticated-orcid":false,"given":"Vijay Durga Pradeep","family":"Ganipineni","sequence":"first","affiliation":[{"name":"Department of Medicine, Andhra Medical College, Visakhapatnam 530002, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahas Reddy","family":"Jitta","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Mercy Hospital, Saint Louis, MO 63141, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan Chandra Vinay Bharadwaj","family":"Gudiwada","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Nebraska Medical Center, Chicago, IL 60657, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6044-6085","authenticated-orcid":false,"given":"Jaswanth Rao","family":"Jasti","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of South Dakota, Sioux Falls, SD 57108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitra","family":"Janga","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Jefferson Abington Hospital, Abington, PA 19001, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4729-300X","authenticated-orcid":false,"given":"Bhavyasri","family":"Merugu","sequence":"additional","affiliation":[{"name":"Department of Medicine, MediCiti Institute of Medical Science, Hyderabad 501401, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1817-2839","authenticated-orcid":false,"given":"Revanth Reddy","family":"Bandaru","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, East Carolina University, Greenville, NC 27834, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5880-0356","authenticated-orcid":false,"given":"Srikanth","family":"Puli","sequence":"additional","affiliation":[{"name":"Department of Hospital Medicine, Cheshire Medical Center, Keene, NH 03431, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikramaditya Samala","family":"Venkata","sequence":"additional","affiliation":[{"name":"Department of Hospital Medicine, Cheshire Medical Center, Keene, NH 03431, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7756-6606","authenticated-orcid":false,"given":"Advait","family":"Vasavada","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupak","family":"Desai","sequence":"additional","affiliation":[{"name":"Independent Researcher, Atlanta, GA 30079, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1164\/rccm.201209-1640OC","article-title":"Causes and Circumstances of Death in Pulmonary Arterial Hypertension","volume":"188","author":"Tonelli","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1161\/CIRCRESAHA.115.301146","article-title":"Pulmonary Arterial Hypertension: The Clinical Syndrome","volume":"115","author":"Lai","year":"2014","journal-title":"Circ. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2022","journal-title":"Eur. Respir. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cardfail.2013.12.001","article-title":"Detection of high-sensitivity troponin in outpatients with stable pulmonary hypertension identifies a subgroup at higher risk of adverse outcomes","volume":"20","author":"Roy","year":"2014","journal-title":"J. Card. Fail."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.21037\/cdt-20-370","article-title":"Diagnosis and treatment of right ventricular dysfunction in congenital heart disease","volume":"10","author":"Santens","year":"2020","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jacc.2021.01.011","article-title":"A Test in Context: Interpretation of High-Sensitivity Cardiac Troponin Assays in Different Clinical Settings","volume":"77","author":"Raber","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/cvr\/cvx183","article-title":"Cardiac troponins: From myocardial infarction to chronic disease","volume":"113","author":"Park","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e1230","DOI":"10.1002\/cl2.1230","article-title":"PRISMA2020: An R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell Syst. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Aromataris, E., Lockwood, C., Porritt, K., Pilla, B., and Jordan, Z. (2024). JBI Manual for Evidence Synthesis, JBI. Available online: https:\/\/synthesismanual.jbi.global.","DOI":"10.46658\/JBIMES-24-01"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/chd.12022","article-title":"High-sensitivity Troponin T Is Associated with Poor Outcome in Adults with Pulmonary Arterial Hypertension due to Congenital Heart Disease","volume":"8","author":"Schuuring","year":"2012","journal-title":"Congenit. Heart Dis."},{"key":"ref_12","first-page":"A17161","article-title":"Abstract 17161: High-sensitivity Troponin T Predicts Mortality Independently of Ventricular Dysfunction and Pulmonary Hypertension in Stable Chronic Obstructive Pulmonary Disease","volume":"140","author":"Kvisvik","year":"2019","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"A13252","DOI":"10.1161\/circ.132.suppl_3.13252","article-title":"Abstract 13252: High-sensitivity Troponin T is a Useful Biomarker of Hemodynamics Response After Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension","volume":"132","author":"Kimura","year":"2015","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1183\/09031936.00067011","article-title":"Sensitive cardiac troponin I predicts poor outcomes in pulmonary arterial hypertension","volume":"39","author":"Heresi","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1042\/CS20100014","article-title":"High-sensitive troponin T: A novel biomarker for prognosis and disease severity in patients with pulmonary arterial hypertension","volume":"119","author":"Filusch","year":"2010","journal-title":"Clin. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Kriechbaum, S.D., Wiedenroth, C.B., Keller, T., Wolter, J.S., Ajnwojner, R., Peters, K., Haas, M.A., Roller, F.C., Breithecker, A., and Rieth, A.J. (2018). Dynamics of high-sensitivity cardiac troponin T during therapy with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0204683"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.amjcard.2013.02.036","article-title":"Association of Cardiac Troponin I with Disease Severity and Outcomes in Patients with Pulmonary Hypertension","volume":"111","author":"Ayers","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/VHRM.S300002","article-title":"Cardiac Troponins: Contemporary Biological Data and New Methods of Determination","volume":"17","author":"Chaulin","year":"2021","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.ajem.2019.12.007","article-title":"An emergency medicine approach to troponin elevation due to causes other than occlusion myocardial infarction","volume":"38","author":"Long","year":"2019","journal-title":"Am. J. Emerg. Med."},{"key":"ref_20","first-page":"40","article-title":"Prognostic value of cardiac-specific troponins in chronic obstructive pulmonary disease exacerbations: A systematic review","volume":"55","author":"Chaudary","year":"2014","journal-title":"J. Miss. State Med. Assoc."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Wang, T.K.M., Dugo, C., Whalley, G., Wynne, Y., Semple, H., Smith, K., Cleave, P., Christiansen, J., To, A., and Amir, N. (2018). Diagnostic Utility of High Sensitivity Troponins for Echocardiographic Markers of Structural Heart Disease. Med. Sci., 6.","DOI":"10.3390\/medsci6010017"},{"key":"ref_22","first-page":"411","article-title":"Troponin elevation in other conditions than acute coronary syndromes","volume":"75","author":"Masri","year":"2017","journal-title":"Ann. Biol. Clin."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2147\/VHRM.S315376","article-title":"Clinical and Diagnostic Value of Highly Sensitive Cardiac Troponins in Arterial Hypertension","volume":"17","author":"Chaulin","year":"2021","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.amjcard.2018.01.004","article-title":"Relative Prognostic Value of Cardiac Troponin I and C-Reactive Protein in the General Population (from the Nord-Tr\u00f8ndelag Health [HUNT] Study)","volume":"121","author":"Sigurdardottir","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/crj.12991","article-title":"Serum cardiac troponin elevation predicts mortality in patients with pulmonary hypertension: A meta-analysis of eight cohort studies","volume":"13","author":"Yang","year":"2019","journal-title":"Clin. Respir. J."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/12\/20\/2037\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:13:05Z","timestamp":1760112785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/12\/20\/2037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":25,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2024,10]]}},"alternative-id":["healthcare12202037"],"URL":"https:\/\/doi.org\/10.3390\/healthcare12202037","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]}}}